Composition for treatment of cervix cancer
AssigneeSnu R&Db Foundation
InventorsYoung Kee Shin, Hun Soon Jung, Yu Kyoung Oh
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for the treatment of cervix cancer, more precisely a composition for the treatment of cervix cancer comprising the first active part containing human papilloma virus (referred as “HPV” hereinafter) specific siRNA as an active ingredient and the second active part containing an anticancer agent as an active ingredient. The composition for the treatment of cancer of the present invention has better anticancer effect than the single therapy of the HPV specific siRNA or the anticancer agent, and has an advantage of reducing side effects by using the anticancer agent at a low concentration.
Claims15
A composition for the treatment of cancer composed of the first active part containing human papilloma virus (referred as “HPV” hereinafter) specific siRNA as an active ingredient and the second active part containing an anticancer agent at a low concentration as an active ingredient.
A method for treating cancer comprising the following steps:
- 1) administering the effective dose of the HPV specific siRNA to a patient once or twice for 24 hours;
- and
- 2) administering the effective dose of the anticancer agent at a low concentration to the patient for 4-7 days.
A method for treating cancer comprising the following steps:
- 1) irradiating a patient;
- and 2) administering the effective dose of the anticancer agent at a low concentration to the patient for 4-7 days.
Dependencies are inferred from the claim text.